Heterogeneity in recent‐onset type 1 diabetes – a clinical trial perspective
暂无分享,去创建一个
[1] W. Scherbaum,et al. Age‐dependent decline of β‐cell function in type 1 diabetes after diagnosis: a multi‐centre longitudinal study , 2014, Diabetes, obesity & metabolism.
[2] J. Lachin,et al. Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial , 2014, Diabetes.
[3] Darrell M. Wilson,et al. B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results , 2014, Diabetes Care.
[4] Darrell M. Wilson,et al. Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials , 2013, The Lancet.
[5] P. Marchetti,et al. Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes , 2013, Diabetes.
[6] Å. Lernmark,et al. Decline of C-peptide during the first year after diagnosis of Type 1 diabetes in children and adolescents. , 2013, Diabetes research and clinical practice.
[7] M. Redondo,et al. Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes , 2012, Pediatric diabetes.
[8] C. Beam,et al. Fall in C-Peptide During First 2 Years From Diagnosis , 2012, Diabetes.
[9] Juan Pedro López,et al. GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. , 2012, The New England journal of medicine.
[10] Darrell M. Wilson,et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial , 2011, The Lancet.
[11] Darrell M. Wilson,et al. Failure to Preserve β-Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes , 2010, Diabetes Care.
[12] Darrell M. Wilson,et al. Failure to Preserve beta-cell function with Mycophenolate Mofetil and Daclizumab Combined Therapy in patients with new onset Type 1 Diabetes Running title: MMF and DZB in New Onset T1D , 2010 .
[13] M. Steffes,et al. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial. , 2003, Diabetes care.
[14] Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. , 1994, Vital and health statistics. Ser. 1, Programs and collection procedures.